Top Stories
-
Explore pioneering work in AI, cell therapy and immunotherapy, and our approach to compassionate, community-informed care in the 2024 Pathways to a Cure annual report.
Topic
-
Researchers Rebecca Kehm, PhD and Lauren Houghton, PhD, shed light on an emerging trend in early onset breast cancer, pointing to early adolescence as a key window that could provide needed answers.
Topic
-
A new advisory on how alcohol increases cancer risk addresses the growing body of evidence about alcohol’s harmful health impacts, including its direct link to cancer.
Topic
-
Join us in celebrating HICCC's top stories of the year.
Topic
Latest News
- September 10, 2024
Two FDA approved drugs show promise in muscle-invasive bladder cancer in mice by transforming tumors into a more benign subtype.
Topic
- September 3, 2024
The Columbia-led Nature study identified PrecisionChain as a solution to access vital genetic and clinical data and advance precision medicine studies.
- August 27, 2024
The ketogenic diet may increase the risk of tumor metastasis according to a new study led by Wei Gu, PhD.
- August 19, 2024
Study led by Melissa Beauchemin, PhD, highlights that inadequate translation and interpretation services in the U.S. contributes to lack of representation in cancer clinical trials.
Topic
-
Source:
CUIMC NewsroomAugust 15, 2024A first of its kind study, co led by Swarnali Acharyya, PhD, to identify an FDA approved drug to ward off cancer cells that overcome PARP inhibitors.
Topic
- May 28, 2024
Including BRCA1 testing at the time of obstetrical prenatal carrier screening could identify at-risk people at a time when cancer screening could save their life.
Topic
- May 22, 2024
New proof-of-concept study in Nature Biotechnology shows that changing only a single letter in the DNA code of selected genes in T cells may lead to improved cell therapy.
Topic
- May 6, 2024
Ken Olive’s work focuses on translating new discoveries in the lab into lifesaving treatments for pancreatic cancer patients.
Topic
-
Source:
CUIMC NewsroomApril 8, 2024A new type of investigational therapeutic for pancreatic cancer has shown unprecedented tumor-fighting abilities in preclinical models of the disease.
Topic
- April 2, 2024
Dozens of HICCC researchers will present their research at this year's AACR annual meeting.
